MXCT vs TT
MaxCyte Inc (MXCT) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
MXCT currently screens at market cap $124.3M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the MXCT and TT stock pages for the full models.
Not investment advice.